Royal Bank Of Canada Arca Biopharma, Inc. Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
A detailed history of Royal Bank Of Canada transactions in Arca Biopharma, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 56 shares of ABIO stock, worth $214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 56
-0.0%
Holding current value
$214
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABIO
# of Institutions
25Shares Held
7.23MCall Options Held
54.7KPut Options Held
0-
Cable Car Capital LLC San Francisco, CA4MShares$15.3 Million9.73% of portfolio
-
Western Standard LLC Los Angeles, CA1.41MShares$5.4 Million1.2% of portfolio
-
Bml Capital Management, LLC Zionsville, IN707KShares$2.71 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA454KShares$1.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY231KShares$885,6410.0% of portfolio
About ARCA biopharma, Inc.
- Ticker ABIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,410,100
- Market Cap $55.2M
- Description
- ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...